Retail Earnings, Pharma Blow, and Semi Bulls Dominate

Retail Earnings in Focus

This week belongs to retail. Home Depot and Target both report Wednesday, while Lowe's and TJX Companies also release results. Investors are watching for tariff impact signals across home improvement and consumer spending. Toll Brothers analysts are already revising forecasts ahead of today's call.

Pharma Takes a Court Hit

The Supreme Court upheld Biden-era Medicare drug pricing rules this morning — a major blow to Big Pharma. Options traders rushed for put protection across the sector. AbbVie, Bristol-Myers Squibb, Pfizer, and Johnson & Johnson all saw active near-dated puts. The ruling hits European names too. AstraZeneca and Novo Nordisk face fresh pricing risk on US-sold drugs.

Semis Catch a Bid

Analysts raised targets on Micron, Intel, and SanDisk today. The call: AI demand has more room to run. Applied Materials also saw its consensus target nudge higher. CrowdStrike added to the tech bullishness, with 41 analyst buy ratings and a fresh $510 consensus target. Short interest in the sector remains low — bears are not betting against the rally.

Short Sellers and Insider Split

Wolfspeed short interest hit 107% of free float — up 36 points in a week. The distressed chipmaker is being aggressively shorted despite a 250% three-month price rally. On insiders, General Atlantic filed $32.9M in purchases of Alkami Technology. DraftKings co-founder Matt Kalish filed $31.7M in sales on the other side of the ledger.